Emergency Medications Quiz

Epinephrine is the first-line treatment for severe allergic reactions due to its rapid onset and vasoconstrictive effects, counteracting anaphylaxis symptoms.

Albuterol acts as a bronchodilator, relieving bronchospasms in acute asthma attacks by stimulating beta-2 receptors in the airways.

Naloxone is administered to reverse opioid overdose by competitively binding to opioid receptors, restoring respiratory function.

Fentanyl is commonly used for sedation and analgesia in mechanically ventilated patients due to its rapid onset, short duration, and potent opioid effects.

Epinephrine is the first-line treatment for anaphylaxis, providing rapid relief by counteracting allergic response symptoms.

N-acetylcysteine is the antidote for acetaminophen overdose, replenishing glutathione and preventing hepatotoxicity.

Etomidate is preferred for RSI due to its rapid onset, stable hemodynamics, and minimal impact on respiratory function.

Lorazepam is the first-line treatment for status epilepticus, exerting rapid anticonvulsant effects by enhancing GABAergic transmission.

Tissue plasminogen activator (tPA) is the first-line treatment for acute ischemic stroke, promoting clot dissolution and restoring blood flow.

Flumazenil is the antidote for benzodiazepine overdose, reversing sedative effects by competitively blocking benzodiazepine receptors.

Epinephrine is a vasopressor used in cardiac arrest to enhance coronary perfusion pressure and improve overall chances of successful resuscitation.

Lidocaine is the medication of choice for acute management of ventricular fibrillation or pulseless ventricular tachycardia, stabilizing cardiac cell membranes and preventing arrhythmias.

Hydroxocobalamin is commonly used as an antidote for cyanide poisoning, binding with cyanide to form non-toxic cyanocobalamin.

Protamine sulfate is the antidote for heparin overdose, neutralizing the anticoagulant effects of heparin.

Vitamin K is the antidote for warfarin overdose, promoting the synthesis of clotting factors and reversing the anticoagulant effects of warfarin.